Shuiying Hu

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (13)

Stefan Oswald

GERMANY

View details

Stefan Buck

NETHERLANDS

View details

Micheline Piquette-Miller

Professor

University of Toronto

CANADA

View details

Jason Sprowl

Assistant Professor

University at Buffalo

UNITED STATES

View details

Noora Sjöstedt

University of Helsinki

FINLAND

View details

Przemysław Radwański

Assistant Professor

Ohio State University

UNITED STATES

View details

Eric Eisenmann

Ohio State University

UNITED STATES

View details

Sharyn D. Baker

Ohio State University

UNITED STATES

View details

Wytske M. van Weerden

Erasmus University Medical Center

NETHERLANDS

View details

Ken-ichi Fujita

department of clinical pharmacy showa medical university school of pharmacy hatanodai

JAPAN

View details

Wei Yue

UNITED STATES

View details

Xiaolin Cheng

Associate Professor

Ohio State University

UNITED STATES

View details

Henriette E. Meyer zu Schwabedissen

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shuiying Hu

Research Interests

Explore related searches

Contact this professor

Articles (15)

Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice

OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.

Strain-dependent neuronal disposition and toxicity of paclitaxel in mice

Darolutamide does not interfere with OATP‐mediated uptake of docetaxel

Quantification of the aromatase inhibitor letrozole and its carbinol metabolite in mouse plasma by UHPLC-MS/MS

Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice.

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy.

Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity

Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity

In Vitro and In Vivo Inhibition of MATE1 by Tyrosine Kinase Inhibitors

Collaborators (13)

Stefan Oswald

Stefan Buck

Micheline Piquette-Miller

Jason Sprowl

Noora Sjöstedt

Przemysław Radwański

Eric Eisenmann

Sharyn D. Baker

Wytske M. van Weerden

Ken-ichi Fujita

Wei Yue

Xiaolin Cheng

Henriette E. Meyer zu Schwabedissen

Make your next move.